Actelion awarded the Prix Hermès de l'Innovation
The European Institute for Creative Strategies and Innovation awards the Prix Hermès annually to selected institutions and companies in recognition of their outstanding innovative achievements in different areas of life. It includes a total of eight different categories. The award ceremony will take place in Paris on April 19th.
Actelion receives the Prix Hermès for its extensive innovative research work for improving the quality of life of patients. In particular, the Prize recognizes Actelion's commitment to improve treatment of children with rare diseases, especially in pulmonary arterial hypertension.
Martine Clozel, Chief Scientific Officer of Actelion, said: "We are honored to be awarded this Prize, which acknowledges the commitment of Actelion to innovative research for the benefit of patients with rare diseases. In particular, it recognizes our efforts to help children. With Tracleer, we began developing a formulation adapted to children with pulmonary arterial hypertension particularly early in the development".
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.